Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Plasma cell myeloma recurrent

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Italy

Participants:65+ years
Substances:Dexamethasone

Contact Research Centre

Lupus nephritis

Not recruiting

Registered drug

Study on Anifrolumab for Adults with Active Lupus Nephritis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Anifrolumab

Contact Research Centre

Lupus nephritis+1

Not recruiting

Investigational

Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Vemircopan

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drug

Study on Setanaxib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Adult T-cell lymphoma/leukaemia+2

Not recruiting

Registered drugNo placebo

Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Etoposide

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Pirtobrutinib

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis and Myeloproliferative Neoplasms

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Celecoxib

Contact Research Centre

Find therapies in clinical trials near you – page 37

554 trials match your criteria

Cardiac failure chronic+1

Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

Major depression

Study on the Effectiveness and Safety of REL-1017 for Patients with Major Depression Who Have Not Responded to Current Treatment

Myasthenia gravis

Study on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis

Chronic lymphocytic leukaemia

Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Hidradenitis

Study on the Long-Term Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Plasma cell myeloma recurrent

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Lupus nephritis

Study on Anifrolumab for Adults with Active Lupus Nephritis

Lupus nephritis+1

Study on Vemircopan for Adults with Lupus Nephritis or IgA Nephropathy

Squamous cell carcinoma of head and neck

Study on Setanaxib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Adult T-cell lymphoma/leukaemia+2

Study of Selinexor, Ifosfamide, Etoposide, and Dexamethasone for Patients with Relapsed or Refractory Peripheral T-cell Lymphomas

Chronic lymphocytic leukaemia

Study Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Myelofibrosis+1

Study on the Safety and Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis and Myeloproliferative Neoplasms

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.